Keng‐Hsueh Lan - Concepedia

Author

Keng‐Hsueh Lan

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

K Lan, K. Lan, K.-H. Lan, KENG‐HSUEH LAN, Keng-Hsueh Lan, Keng-hsueh Lan, Keng‐Hsueh Lan

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center National Taiwan University Hospital National Taiwan University National Yang Ming Chiao Tung University Taipei Veterans General Hospital

About

Keng‐Hsueh Lan is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	2.4K
2	Cell Biology	4	4	518
3	Immunology	2	2	1.9K
4	Natural Sciences	1	1	129
5	Biochemistry	1	1	129

Keng‐Hsueh Lan

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients Yoichi Nagata, Keng‐Hsueh Lan, Xiaoyan Zhou, Cancer Cell Trastuzumab ResistancePten Activation ContributesMedicinePharmacologyImmunology	2004	1.8K
Activation of the Akt/Mammalian Target of Rapamycin/4E-BP1 Pathway by ErbB2 Overexpression Predicts Tumor Progression in Breast Cancers Xiaoyan Zhou, Ming Tan, Valerie Stone Hawthorne, Clinical Cancer Research	2004	312
Preclinical Testing of Clinically Applicable Strategies for Overcoming Trastuzumab Resistance Caused by PTEN Deficiency Chien‐Hsing Lu, Shannon L. Wyszomierski, Ling‐Ming Tseng, Clinical Cancer Research	2007	194
14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival Christopher L. Neal, Jun Yao, Wentao Yang, Cancer Research Tumor BiologyBreast Cancer RecurrenceBreast OncologyEndocrine-related CancerCancer Risk	2009	174
Phosphorylation on Tyrosine-15 of p34Cdc2 by ErbB2 Inhibits p34Cdc2 Activation and Is Involved in Resistance to Taxol-Induced Apoptosis Ming Tan, Jing Tong, Keng‐Hsueh Lan, Molecular Cell Signal TransductionBiochemistryTaxol-induced ApoptosisNatural SciencesIs Involved	2002	129
Selective Inhibition of ErbB2-Overexpressing Breast Cancer <i>In vivo</i> by a Novel TAT-Based ErbB2-Targeting Signal Transducers and Activators of Transcription 3–Blocking Peptide Ming Tan, Keng‐Hsueh Lan, Jun Yao, Cancer Research	2006	121
Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells. Sangkyou Lee, Wentao Yang, Keng‐Hsueh Lan, PubMed Breast OncologyTaxol-induced ApoptosisApoptosisCell DeathCancer Biology	2002	109
ErbB2 Promotes Src Synthesis and Stability: Novel Mechanisms of Src Activation That Confer Breast Cancer Metastasis Ming Tan, Ping Li, Kristine S. Klos, Cancer Research Tumor BiologyRadiation OncologySrc KinaseBreast OncologyCell Regulation	2005	106
Clinicopathologic features and responses to radiotherapy of myeloid sarcoma Chunwei Wang, Chin‐Hao Chang, Heng‐Hsiu Liu, Radiation Oncology	2013	30
Prolonged Treatment Time Deteriorates Positioning Accuracy for Stereotactic Radiosurgery Chunwei Wang, Yin-Chun Lin, Ham‐Min Tseng, PLoS ONE	2015	26

Page 1